Development of PSD95 Inhibitors for the Treatment of Stroke: From Bench to Phase 3 Clinical Trials

Event Date:

Thursday, February 6, 2014 - 12:00am

Mike Tymianski, MD/PhD, Director of Neurovascular Therapeutics, Head of Neurosurgery, University Health Network